Published in J Bone Miner Res on June 01, 2014
Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial. Lancet (2015) 1.57
Trabecular bone score (TBS) as a new complementary approach for osteoporosis evaluation in clinical practice. Bone (2015) 1.08
Osteoporotic Fracture: 2015 Position Statement of the Korean Society for Bone and Mineral Research. J Bone Metab (2015) 0.89
Multiscale Predictors of Femoral Neck In Situ Strength in Aging Women: Contributions of BMD, Cortical Porosity, Reference Point Indentation, and Nonenzymatic Glycation. J Bone Miner Res (2015) 0.85
Goal-directed treatment of osteoporosis in Europe. Osteoporos Int (2014) 0.84
Measurement of cortical porosity of the proximal femur improves identification of women with nonvertebral fragility fractures. Osteoporos Int (2015) 0.81
Examining the Relationships Between Bone Tissue Composition, Compositional Heterogeneity, and Fragility Fracture: A Matched Case-Controlled FTIRI Study. J Bone Miner Res (2015) 0.81
Effects of Two Years of Teriparatide, Denosumab, or Both on Bone Microarchitecture and Strength (DATA-HRpQCT study). J Clin Endocrinol Metab (2016) 0.81
Estrogens and Androgens in Skeletal Physiology and Pathophysiology. Physiol Rev (2017) 0.81
Spatial distribution of intracortical porosity varies across age and sex. Bone (2015) 0.80
Skeletal changes through the lifespan--from growth to senescence. Nat Rev Endocrinol (2015) 0.80
High prevalence of secondary factors for bone fragility in patients with a recent fracture independently of BMD. Arch Osteoporos (2016) 0.80
Microarchitecture and Peripheral BMD are Impaired in Postmenopausal White Women With Fracture Independently of Total Hip T-Score: An International Multicenter Study. J Bone Miner Res (2016) 0.79
Growth and Age-Related Abnormalities in Cortical Structure and Fracture Risk. Endocrinol Metab (Seoul) (2015) 0.78
Changes in Nonosteoporotic Bone Density and Subsequent Fractures in Women. South Med J (2016) 0.76
Role of endocortical contouring methods on precision of HR-pQCT-derived cortical micro-architecture in postmenopausal women and young adults. Osteoporos Int (2015) 0.76
Diminished bone strength is observed in adult women and men who sustained a mild trauma distal forearm fracture during childhood. J Bone Miner Res (2014) 0.76
Intrinsic mechanical behavior of femoral cortical bone in young, osteoporotic and bisphosphonate-treated individuals in low- and high energy fracture conditions. Sci Rep (2016) 0.76
Cortical porosity not superior to conventional densitometry in identifying hemodialysis patients with fragility fracture. PLoS One (2017) 0.76
Prevalent role of porosity and osteonal area over mineralization heterogeneity in the fracture toughness of human cortical bone. J Biomech (2016) 0.75
Changes in bone macro- and microstructure in diabetic obese mice revealed by high resolution microfocus X-ray computed tomography. Sci Rep (2016) 0.75
Molecular Abnormalities Underlying Bone Fragility in Chronic Kidney Disease. Biomed Res Int (2017) 0.75
Heritability and Genetic Correlations for Bone Microarchitecture: The Framingham Study Families. J Bone Miner Res (2016) 0.75
In vivo evaluation of bone microstructure in humans: Clinically useful? Bonekey Rep (2016) 0.75
Predicting bone strength with ultrasonic guided waves. Sci Rep (2017) 0.75
Quantitative imaging methods in osteoporosis. Quant Imaging Med Surg (2016) 0.75
Value of Measuring Bone Microarchitecture in Fracture Discrimination in Older Women with Recent Hip Fracture: A Case-control Study with HR-pQCT. Sci Rep (2016) 0.75
The clinical contribution of cortical porosity to fragility fractures. Bonekey Rep (2016) 0.75
SERMs have substance-specific effects on bone, and these effects are mediated via ERαAF-1 in female mice. Am J Physiol Endocrinol Metab (2016) 0.75
Non-destructive NIR spectral imaging assessment of bone water: Comparison to MRI measurements. Bone (2017) 0.75
Bone microstructure in men assessed by HR-pQCT: Associations with risk factors and differences between men with normal, low, and osteoporosis-range areal BMD. Bone Rep (2016) 0.75
Cortical bone laminar analysis reveals increased midcortical and periosteal porosity in type 2 diabetic postmenopausal women with history of fragility fractures compared to fracture-free diabetics. Osteoporos Int (2016) 0.75
Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics (1988) 70.41
Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. Am J Epidemiol (2004) 12.03
Sick individuals and sick populations. Int J Epidemiol (2001) 9.10
FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int (2008) 8.75
Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group. Osteoporos Int (1994) 5.72
Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study. Bone (2004) 5.27
Intracortical remodelling and porosity in the distal radius and post-mortem femurs of women: a cross-sectional study. Lancet (2010) 4.08
Bone mineral density thresholds for pharmacological intervention to prevent fractures. Arch Intern Med (2004) 3.93
A reference standard for the description of osteoporosis. Bone (2007) 3.67
The compressive behavior of bone as a two-phase porous structure. J Bone Joint Surg Am (1977) 3.12
The burden of osteoporotic fractures: a method for setting intervention thresholds. Osteoporos Int (2001) 2.81
Cortical bone water: in vivo quantification with ultrashort echo-time MR imaging. Radiology (2008) 2.71
Age- and gender-related differences in the geometric properties and biomechanical significance of intracortical porosity in the distal radius and tibia. J Bone Miner Res (2010) 2.39
Postmenopausal women with osteopenia have higher cortical porosity and thinner cortices at the distal radius and tibia than women with normal aBMD: an in vivo HR-pQCT study. J Bone Miner Res (2010) 2.34
Reproducibility of direct quantitative measures of cortical bone microarchitecture of the distal radius and tibia by HR-pQCT. Bone (2010) 2.32
Half the burden of fragility fractures in the community occur in women without osteoporosis. When is fracture prevention cost-effective? Bone (2006) 1.81
Assessing forearm fracture risk in postmenopausal women. Osteoporos Int (2009) 1.71
Stiffness of compact bone: effects of porosity and density. J Biomech (1988) 1.65
Fracture risk and height: an association partly accounted for by cortical porosity of relatively thinner cortices. J Bone Miner Res (2013) 1.62
The population burden of fractures originates in women with osteopenia, not osteoporosis. Osteoporos Int (2006) 1.52
The injury mechanisms of osteoporotic upper extremity fractures among older adults: a controlled study of 287 consecutive patients and their 108 controls. Osteoporos Int (2000) 1.44
Bone density and compostiton. Age-related and pathological changes in water and mineral content. J Bone Joint Surg Am (1966) 1.24
The effect of voxel size on high-resolution peripheral computed tomography measurements of trabecular and cortical bone microstructure. Med Phys (2012) 1.17
Expansion of the medullary cavity at the expense of cortex in postmenopausal osteoporosis. Metab Bone Dis Relat Res (1984) 1.15
Repeat low-trauma fractures occur frequently among men and women who have osteopenic BMD. J Bone Miner Res (2009) 1.15
The chemical anatomy of bone. I. A comparative study of bone composition in sixteen vertebrates. J Bone Joint Surg Am (1969) 1.12
Cortical porosity is higher in boys compared with girls at the distal radius and distal tibia during pubertal growth: an HR-pQCT study. J Bone Miner Res (2012) 1.01
Cost-effectiveness of alendronate for the treatment of osteopenic postmenopausal women in Japan. J Bone Miner Res (2013) 1.00
Cortical bone: a target for fracture prevention? Lancet (2010) 0.94
Hierarchical poroelasticity: movement of interstitial fluid between porosity levels in bones. Philos Trans A Math Phys Eng Sci (2009) 0.92
3D characterization of pores in the cortical bone of human femur in the elderly at different locations as determined by synchrotron micro-computed tomography images. Osteoporos Int (2012) 0.90
Histomorphometric assessment of Haversian canal and osteocyte lacunae in different-sized osteons in human rib. Anat Rec A Discov Mol Cell Evol Biol (2003) 0.88
Osteoporosis: the evolution of a scientific term. Osteoporos Int (1992) 0.86
Lower cortical porosity and higher tissue mineral density in Chinese American versus white women. J Bone Miner Res (2014) 0.82
OBSERVATIONS ON THE WATER CONTENT OF BONE. J Bone Joint Surg Br (1964) 0.78
Epidemiology and outcomes of osteoporotic fractures. Lancet (2002) 13.09
A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med (2002) 8.63
Use of a medical records linkage system to enumerate a dynamic population over time: the Rochester epidemiology project. Am J Epidemiol (2011) 8.00
DHEA in elderly women and DHEA or testosterone in elderly men. N Engl J Med (2006) 7.90
Prevalence of monoclonal gammopathy of undetermined significance. N Engl J Med (2006) 7.24
Benign breast disease and the risk of breast cancer. N Engl J Med (2005) 6.84
Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res (2007) 6.76
The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med (2004) 6.55
History of the Rochester Epidemiology Project: half a century of medical records linkage in a US population. Mayo Clin Proc (2012) 6.54
Predictive value of BMD for hip and other fractures. J Bone Miner Res (2005) 6.46
Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev (2002) 6.38
Generalizability of epidemiological findings and public health decisions: an illustration from the Rochester Epidemiology Project. Mayo Clin Proc (2012) 6.21
Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. Ann Intern Med (2005) 5.94
Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res (2013) 5.93
Osteoporosis: now and the future. Lancet (2011) 5.81
New loci associated with kidney function and chronic kidney disease. Nat Genet (2010) 5.58
Assessment of fracture risk. Osteoporos Int (2004) 5.15
Age-related lobular involution and risk of breast cancer. J Natl Cancer Inst (2006) 5.12
Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study. Lancet (2010) 4.75
Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance. Blood (2005) 4.48
Data resource profile: the Rochester Epidemiology Project (REP) medical records-linkage system. Int J Epidemiol (2012) 4.47
Circulating osteoblast-lineage cells in humans. N Engl J Med (2005) 4.19
Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. Arch Intern Med (2002) 4.18
Intracortical remodelling and porosity in the distal radius and post-mortem femurs of women: a cross-sectional study. Lancet (2010) 4.08
Population-based study of age and sex differences in bone volumetric density, size, geometry, and structure at different skeletal sites. J Bone Miner Res (2004) 4.02
Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000. Inflamm Bowel Dis (2007) 3.83
Survival patterns after oophorectomy in premenopausal women: a population-based cohort study. Lancet Oncol (2006) 3.81
Increased prevalence and mortality in undiagnosed celiac disease. Gastroenterology (2009) 3.73
Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants. N Engl J Med (2009) 3.70
A reference standard for the description of osteoporosis. Bone (2007) 3.67
Natural history of asymptomatic mitral valve prolapse in the community. Circulation (2002) 3.40
Why patients visit their doctors: assessing the most prevalent conditions in a defined American population. Mayo Clin Proc (2013) 3.40
Fat tissue, aging, and cellular senescence. Aging Cell (2010) 3.34
FRAX and its applications to clinical practice. Bone (2009) 3.32
Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss. Nat Genet (2011) 3.16
Trends in the mortality burden associated with diabetes mellitus: a population-based study in Rochester, Minn, 1970-1994. Arch Intern Med (2003) 3.13
Psychosocial factors are linked to functional gastrointestinal disorders: a population based nested case-control study. Am J Gastroenterol (2004) 3.11
Effects of sex and age on bone microstructure at the ultradistal radius: a population-based noninvasive in vivo assessment. J Bone Miner Res (2005) 3.11
Mortality, disability, and nursing home use for persons with and without hip fracture: a population-based study. J Am Geriatr Soc (2002) 3.09
Role of RANK ligand in mediating increased bone resorption in early postmenopausal women. J Clin Invest (2003) 3.09
Randomized, placebo-controlled trial of clodronate in patients with primary operable breast cancer. J Clin Oncol (2002) 3.01
A meta-analysis of prior corticosteroid use and fracture risk. J Bone Miner Res (2004) 2.92
Prevalence of monoclonal gammopathy of undetermined significance among men in Ghana. Mayo Clin Proc (2007) 2.91
Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community. Gastroenterology (2003) 2.89
Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma. Blood (2007) 2.87
Risk of intestinal cancer in inflammatory bowel disease: a population-based study from olmsted county, Minnesota. Gastroenterology (2006) 2.87
Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease. Endocr Rev (2007) 2.82
Incidence of childhood distal forearm fractures over 30 years: a population-based study. JAMA (2003) 2.81
Increase in bone marrow lesions associated with cartilage loss: a longitudinal magnetic resonance imaging study of knee osteoarthritis. Arthritis Rheum (2006) 2.81
A population-based assessment of rates of bone loss at multiple skeletal sites: evidence for substantial trabecular bone loss in young adult women and men. J Bone Miner Res (2008) 2.76
The cost-effectiveness of alendronate in the management of osteoporosis. Bone (2007) 2.75
CUBN is a gene locus for albuminuria. J Am Soc Nephrol (2011) 2.70
Long-term follow-up of IgM monoclonal gammopathy of undetermined significance. Blood (2003) 2.68
Prevalence and burden of fecal incontinence: a population-based study in women. Gastroenterology (2005) 2.64
Cost-effectiveness of bone densitometry followed by treatment of osteoporosis in older men. JAMA (2007) 2.62
Serum aminotransferase activity and mortality risk in a United States community. Hepatology (2008) 2.61
A prospective, controlled assessment of factors influencing acceptance of screening colonoscopy. Am J Gastroenterol (2002) 2.60
Stratification of breast cancer risk in women with atypia: a Mayo cohort study. J Clin Oncol (2007) 2.58
Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw. J Rheumatol (2008) 2.57
Acute aortic dissection: population-based incidence compared with degenerative aortic aneurysm rupture. Mayo Clin Proc (2004) 2.55
Structural and biomechanical basis of sexual dimorphism in femoral neck fragility has its origins in growth and aging. J Bone Miner Res (2003) 2.48
Changes in bone mineral density explain little of the reduction in vertebral or nonvertebral fracture risk with anti-resorptive therapy. Bone (2004) 2.48
Trends in the identification and clinical features of celiac disease in a North American community, 1950-2001. Clin Gastroenterol Hepatol (2003) 2.47
Older men with low serum estradiol and high serum SHBG have an increased risk of fractures. J Bone Miner Res (2008) 2.44
Long-term follow-up of 241 patients with monoclonal gammopathy of undetermined significance: the original Mayo Clinic series 25 years later. Mayo Clin Proc (2004) 2.43
Prevalence and trends in low femur bone density among older US adults: NHANES 2005-2006 compared with NHANES III. J Bone Miner Res (2010) 2.40
Regulation of bone formation by osteoclasts involves Wnt/BMP signaling and the chemokine sphingosine-1-phosphate. Proc Natl Acad Sci U S A (2008) 2.39
Teriparatide therapy for alendronate-associated osteonecrosis of the jaw. N Engl J Med (2010) 2.38
Alcohol intake as a risk factor for fracture. Osteoporos Int (2004) 2.34
Effects of suppression of follicle-stimulating hormone secretion on bone resorption markers in postmenopausal women. J Clin Endocrinol Metab (2010) 2.33
For estimating creatinine clearance measuring muscle mass gives better results than those based on demographics. Kidney Int (2009) 2.32
Incidence of multiple myeloma in Olmsted County, Minnesota: Trend over 6 decades. Cancer (2004) 2.31
Kidney stones and the risk for chronic kidney disease. Clin J Am Soc Nephrol (2009) 2.22
Does osteoporosis therapy invalidate FRAX for fracture prediction? J Bone Miner Res (2012) 2.22
Long-term survival of patients with anorexia nervosa: a population-based study in Rochester, Minn. Mayo Clin Proc (2003) 2.21
Assessment of the 10-year probability of osteoporotic hip fracture combining clinical risk factors and heel bone ultrasound: the EPISEM prospective cohort of 12,958 elderly women. J Bone Miner Res (2008) 2.20
Silent pain sufferers. Mayo Clin Proc (2006) 2.20
Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993-2001: an update on the changing epidemiology of the disease. J Bone Miner Res (2005) 2.15
Osteoporosis: burden, health care provision and opportunities in the EU: a report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos (2011) 2.14
The perspective of the international osteoporosis foundation on the official positions of the international society for clinical densitometry. J Clin Densitom (2005) 2.14